FEATURE ARTICLES
Contamination control gaps arise when two dynamics merge — when processes become familiar and workloads increase. Here's how to spot them before they spin out of control.
- SUS Interchangeability Assessment And Qualification Best Practices
- New MIT Consortium Links Innovation With Real-World Biomanufacturing
- 9 Pharma Trends To Watch In 2026
- Process Engineering's Key Role In Sterile Injectable Facility Design
- Rethinking Product Development Through Lipid-Based Formulations
- What To Know About — And How To Apply For — FDA's PreCheck Pilot
- MES Is Still In The CD ROM Era But The Data Architecture Has Moved On
PHARMA ONLINE WHITE PAPERS
-
A Journey To Boundless Automation In Life Sciences
Boundless automation reimagines industrial computing through seamless integration of the intelligent field, edge, and cloud, unified by a real-time data fabric that enables digital transformation.
-
Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap7/23/2025
As biopharma complexity grows, flexible CDMOs are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.
-
Transformative Innovation: Advancing Drug Development Using In Silico Modeling3/4/2026
Explore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.
-
Best Practices For Internal Quality Audits In Life Sciences3/14/2025
Discover why internal quality audits are vital in the life sciences sector to ensure regulatory compliance, mitigate risks, and maintain high standards of product quality and patient safety amidst evolving challenges.
-
Best Practices In Commissioning And Qualification7/5/2024
An integrated approach to C&Q ensures coordination and synchronization between commissioning and qualification activities, enhancing both regulatory compliance and product safety.
-
Epigenetics Application Guide10/2/2024
To fully understand biology and disease mechanisms, it is crucial to explore the role of epigenetic factors. Explore how epigenetic regulation works and methods to study these essential components.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Asset Reinduction To Maximo EAM, Enabled By Reality Capture
- Vial Adapter Transfer Device Compatibility With Cell Therapies
- Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS
- Advancing Cell Therapy Manufacturing: Rapid Sterility Testing
- Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis
NEWSLETTER ARCHIVE
- 03.14.26 -- Pharmaceutical Online Best Of February
- 03.13.26 -- Process Engineering's Key Role In Sterile Injectable Facility Design
- 03.12.26 -- 9 Pharma Trends To Watch In 2026
- 03.12.26 -- STREAM Edition: Importance Of Architectural Layout To Prevent Contamination
- 03.11.26 -- Where AI Is Paying Off Across The Drug Development Lifecycle
INDUSTRY NEWS
-
Høeg In, Pazdur Out At The FDA
What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
9 Drugs Granted Fast Track By FDA's Voucher Program
With targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
Leaders In The Excipient Market: Region And Type
Though North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
Pfizer Strengthens Obesity Foothold With Metsera Acquisition
After discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
FDA Cracks Down On GLP-1 Imports
GLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
ROSS PDDM-10 Planetary Dual Disperser Delivers Unmatched Pilot-Scale Processing Flexibility3/10/2026
The ROSS Model PDDM-10 Planetary Dual Disperser is a near-universal pilot scale mixer designed to deliver high shear and controlled planetary agitation under vacuum, enabling rapid solids dispersion and producing air-free, high-quality pastes, slurries, gels and putties. It can also handle powder blending, granulation and vacuum drying requirements. This mixer processes up to 12 gallons per batch with a full holding capacity of 15 gallons.
-
Forma Life Sciences Launches U.S. Based Contract Development And Manufacturing Organization (CDMO) For Oral Solid Dosage Development And Commercial Manufacturing In Irvine, California3/6/2026
Forma Life Sciences, Inc. today announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on oral solid dosage formulation development, clinical manufacturing, and commercial drug product manufacturing in the United States.
-
Join Esco At INTERPHEX 20263/3/2026
-
Ensorcell Appoints Biopharma Industry Veterans Geoff Hodge And Amy Teachout To Senior Leadership Team3/3/2026
Ensorcell, a company focused on reimaging life science tools and solutions for the biopharmaceutical industry, today announced the appointment of Geoff Hodge and Amy Teachout to its senior leadership team. These appointments reinforce Ensorcell’s commitment to innovation, superb value, and exceptional customer experience as the company continues to expand its capabilities and partnerships across the biopharma ecosystem.